Role of histone deacetylase 9 in regulating adipogenic differentiation and high fat diet-induced metabolic disease

Adipocyte

Volumn 3, Issue 4, 2014, Pages 333-338

  Chatterjee, Tapan K ^a   Basford, Joshua E ^b   Yiew, Kan Hui ^a   Stepp, David W ^a   Hui, David Y ^b   Weintraub, Neal L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adaptive thermogenesis; Adipogenic differentiation; Adipose tissue dysfunction; Beige adipocytes; Ectopic lipid accumulation; Energy expenditure; Fibroblast growth factor 21; Glucose intolerance; High fat diet; Histone deacetylase 9; Insulin resistance; Metabolic disease; Obesity

Indexed keywords

HISTONE DEACETYLASE 9;

ADIPOGENESIS; CELL DIFFERENTIATION; DOWN REGULATION; ENERGY EXPENDITURE; GENE DELETION; HYPERTROPHY; METABOLIC DISORDER; NONHUMAN; NOTE; OBESITY; PROTEIN EXPRESSION; THERMOGENESIS; UPREGULATION;

EID: 84961381165     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.4161/adip.28814     Document Type: Note

References (50)

1. Berry R, Jeffery E, RodehefferMS. Weighing in on Adipocyte Precursors. Cell Metab 2014; 19:8-20; PMID: 24239569; http://dx.doi.org/10.1016/j.cmet.2013.10.003
2. Joe AW, Yi L, Even Y, Vogl AW, Rossi FM. Depotspecific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Stem Cells 2009; 27:2563-70; PMID:19658193; http://dx.doi.org/10.1002/stem.190
3. Rigamonti A, Brennand K, Lau F, Cowan CA. Rapid cellular turnover in adipose tissue. PLoS One 2011; 6: e17637; PMID:21407813; http://dx.doi.org/10.1371/journal.pone.0017637
4. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Näslund E, Britton T, et al. Dynamics of fat cell turnover in humans. Nature 2008; 453:783-7; PMID:18454136; http://dx.doi.org/10.1038/nature06902
5. Lee YH, Petkova AP, Granneman JG. Identification of an adipogenic niche for adipose tissue remodeling and restoration. Cell Metab 2013; 18:355-67; PMID: 24011071; http://dx.doi.org/10.1016/j.cmet.2013.08.003
6. Wang QA, Tao C, Gupta RK, Scherer PE. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 2013; 19:1338-44; PMID:23995282; http://dx.doi.org/10.1038/nm.3324
7. Blüher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab 2013; 27:163-77; PMID:23731879; http://dx.doi.org/10.1016/j.beem.2013.02.005
8. Hauner H. Adipose tissue inflammation: are small or large fat cells to blame? Diabetologia 2010; 53:223-5; PMID:19937224; http://dx.doi.org/10.1007/s00125-009-1605-3
9. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005; 64: 163-9; PMID:15960861; http://dx.doi.org/10.1079/PNS2005428
10. Chatterjee TK, Basford JE, Knoll E, Tong WS, Blanco V, Blomkalns AL, Rudich S, Lentsch AB, Hui DY, Weintraub NL. HDAC9 knockout mice are protected from adipose tissue dysfunction and systemic metabolic disease during high-fat feeding. Diabetes 2014; 63:176-87; PMID:24101673; http://dx.doi.org/10.2337/db13-1148
11. Cantone I, Fisher AG. Epigenetic programming and reprogramming during development. Nat Struct Mol Biol 2013; 20:282-9; PMID:23463313; http://dx.doi.org/10.1038/nsmb.2489
12. Chatterjee TK, Idelman G, Blanco V, Blomkalns AL, Piegore MG Jr., Weintraub DS, Kumar S, Rajsheker S, Manka D, Rudich SM, et al. Histone deacetylase 9 is a negative regulator of adipogenic differentiation. J Biol Chem 2011; 286:27836-47; PMID:21680747; http://dx.doi.org/10.1074/jbc.M111.262964
13. Chen YH, Yeh FL, Yeh SP, Ma HT, Hung SC, Hung MC, Li LY. Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2. J Biol Chem 2011; 286:10671-80; PMID:21247904; http://dx.doi.org/10.1074/jbc.M110.199612
14. Sun Z, Feng D, Fang B, Mullican SE, You SH, Lim HW, Everett LJ, Nabel CS, Li Y, Selvakumaran V, et al. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. Mol Cell 2013; 52:769-82; PMID: 24268577; http://dx.doi.org/10.1016/j.molcel.2013.10.022
15. Herzig S, Wolfrum C. Brown and white fat: from signaling to disease. Biochim Biophys Acta 2013; 1831:895; PMID:23561705; http://dx.doi.org/10. 1016/j.bbalip.2013.03.009
16. Wu J, Cohen P, Spiegelman BM. Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev 2013; 27:234-50; PMID:23388824; http://dx.doi.org/10.1101/gad.211649.112
17. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009; 360:1500-8; PMID:19357405; http://dx.doi.org/10.1056/NEJMoa0808718
18. Vijgen GH, Bouvy ND, Teule GJ, Brans B, Schrauwen P, van Marken Lichtenbelt WD. Brown adipose tissue in morbidly obese subjects. PLoS One 2011; 6:e17247; PMID:21390318; http://dx.doi.org/10.1371/journal. pone.0017247
19. Vijgen GH, Bouvy ND, Teule GJ, Brans B, Hoeks J, Schrauwen P, van Marken Lichtenbelt WD. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2012; 97:E1229-33; PMID:22535970; http://dx.doi.org/10.1210/jc.2012-1289
20. Schulz TJ, Huang P, Huang TL, Xue R, McDougall LE, Townsend KL, Cypess AM, Mishina Y, Gussoni E, Tseng YH. Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat. Nature 2013; 495:379-83; PMID:23485971; http://dx.doi.org/10.1038/nature11943
21. Lee YH, Petkova AP, Mottillo EP, Granneman JG. In vivo identification of bipotential adipocyte progenitors recruited by b3-adrenoceptor activation and high-fat feeding. Cell Metab 2012; 15:480-91; PMID: 22482730; http://dx.doi.org/10.1016/j.cmet.2012.03.009
22. Ye L, Wu J, Cohen P, Kazak L, Khandekar MJ, Jedrychowski MP, Zeng X, Gygi SP, Spiegelman BM. Fat cells directly sense temperature to activate thermogenesis. Proc Natl Acad Sci U S A 2013; 110:12480-5; PMID:23818608; http://dx.doi.org/10.1073/pnas.1310261110
23. Chen KY, Brychta RJ, Linderman JD, Smith S, Courville A, Dieckmann W, Herscovitch P, Millo CM, Remaley A, Lee P, et al. Brown fat activation mediates cold-induced thermogenesis in adult humans in response to a mild decrease in ambient temperature. J Clin Endocrinol Metab 2013; 98:E1218-23; PMID:23780370; http://dx.doi.org/10.1210/jc.2012-4213
24. Foltz IN, Hu S, King C, Wu X, Yang C, Wang W, Weiszmann J, Stevens J, Chen JS, Nuanmanee N, et al. Treating diabetes and obesity with an FGF21-mimetic antibody activating the bKlotho/FGFR1c receptor complex. Sci Transl Med 2012; 4:ra153; PMID:23197570; http://dx.doi.org/10.1126/scitranslmed.3004690
25. Alisi A, Panera N, Nobili V. Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis. Endocrinology 2014; 155:343-6; PMID:24248463; http://dx.doi.org/10.1210/en.2013-1828
26. Gaich G, Chien JY, Fu H, Glass LC, Deeg MA, Holland WL, Kharitonenkov A, Bumol T, Schilske HK, Moller DE. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab 2013; 18:333-40; PMID:24011069; http://dx. doi.org/10.1016/j.cmet.2013.08.005
27. Yilmaz Y, Eren F, Yonal O, Kurt R, Aktas B, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E. Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. Eur J Clin Invest 2010; 40:887-92; PMID:20624171; http://dx.doi.org/10.1111/j.1365-2362.2010.02338.x
28. Hondares E, Rosell M, Gonzalez FJ, Giralt M, Iglesias R, Villarroya F. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab 2010; 11:206-12; PMID: 20197053; http://dx.doi.org/10.1016/j.cmet.2010.02.001
29. Lee P, Werner CD, Kebebew E, Celi FS. Functional thermogenic beige adipogenesis is inducible in human neck fat. Int J Obes 2014; 38:170-6; PMID:23736373; http://dx.doi.org/10.1038/ijo.2013.82
30. Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, et al. FGF21 regulates PGC-1a and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 2012; 26:271-81; PMID:22302939; http://dx.doi.org/10.1101/gad.177857.111
31. De Sousa-Coelho AL, Relat J, Hondares E, Pérez-Martí A, Ribas F, Villarroya F, Marrero PF, Haro D. FGF21 mediates the lipid metabolism response to amino acid starvation. J Lipid Res 2013; 54:1786-97; PMID: 23661803; http://dx.doi.org/10.1194/jlr.M033415
32. Cuevas-Ramos D, Almeda-Valdes P, Aguilar-Salinas CA, Cuevas-Ramos G, Cuevas-Sosa AA, Gomez-Perez FJ. The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism. Curr Diabetes Rev 2009; 5:216-20; PMID:19531026; http://dx.doi.org/10.2174/157339909789804396
33. Murata Y, Konishi M, Itoh N. FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology. J Nutr Metab 2011; 2011:981315; PMID:21331285; http://dx.doi.org/10.1155/2011/981315
34. Galmozzi A, Mitro N, Ferrari A, Gers E, Gilardi F, Godio C, Cermenati G, Gualerzi A, Donetti E, Rotili D, et al. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 2013; 62:732-42; PMID:23069623; http://dx.doi.org/10.2337/db12-0548
35. Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P, Neddermann P, Sambucini S, Bottomley MJ, Lo Surdo P, Carfí A, et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A 2007; 104:17335-40; PMID: 17956988; http://dx.doi.org/10.1073/pnas.0706487104
36. Zhang CL, McKinsey TA, Olson EN. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc Natl Acad Sci U S A 2001; 98:7354-9; PMID:11390982; http://dx.doi.org/10.1073/pnas.131198498
37. Zhang CL, McKinsey TA, Lu JR, Olson EN. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem 2001; 276:35-9; PMID:11022042; http://dx.doi.org/10.1074/jbc. M007364200
38. Sparrow DB, Miska EA, Langley E, Reynaud-Deonauth S, Kotecha S, Towers N, Spohr G, Kouzarides T, Mohun TJ. MEF-2 function is modified by a novel corepressor, MITR. EMBO J 1999; 18:5085-98; PMID:10487760; http://dx.doi.org/10.1093/emboj/18.18.5085
39. Wong RH, Chang I, Hudak CS, Hyun S, Kwan HY, Sul HS. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell 2009; 136:1056-72; PMID: 19303849; http://dx.doi.org/10.1016/j.cell.2008.12.040
40. M_ejat A, Ramond F, Bassel-Duby R, Khochbin S, Olson EN, Schaeffer L. Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. Nat Neurosci 2005; 8:313-21; PMID:15711539; http://dx.doi.org/10.1038/nn1408
41. Muralidhar SA, Ramakrishnan V, Kalra IS, Li W, Pace BS. Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells. J Biol Chem 2011; 286:2343-53; PMID:21078662; http://dx.doi.org/10.1074/jbc.M110.115725
42. Sugo N, Oshiro H, Takemura M, Kobayashi T, Kohno Y, Uesaka N, Song WJ, Yamamoto N. Nucleocytoplasmic translocation of HDAC9 regulates gene expression and dendritic growth in developing cortical neurons. Eur J Neurosci 2010; 31:1521-32; PMID:20525066
43. Yan K, Cao Q, Reilly CM, Young NL, Garcia BA, Mishra N. Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. J Biol Chem 2011; 286:28833-43; PMID:21708950; http://dx.doi.org/10.1074/jbc.M111.233932
44. Yuan Z, Peng L, Radhakrishnan R, Seto E. Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein. J Biol Chem 2010; 285:39329-38; PMID:20947501; http://dx.doi.org/10.1074/jbc.M110.179333
45. Archer KJ, Mas VR, Maluf DG, Fisher RA. Highthroughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genomics 2010; 283:341-9; PMID:20165882; http://dx.doi.org/10.1007/s00438-010-0522-y
46. Lenoir O, Flosseau K, Ma FX, Blondeau B, Mai A, Bassel-Duby R, Ravassard P, Olson EN, Haumaitre C, Scharfmann R. Specific control of pancreatic endocrine b-and d-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC 9. Diabetes 2011; 60:2861-71; PMID:21953612; http://dx.doi.org/10.2337/db11-0440
47. Zhang CL, McKinsey TA, Olson EN. Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol Cell Biol 2002; 22:7302-12; PMID:12242305; http://dx.doi.org/10.1128/MCB.22.20.7302-7312.2002
48. Beier UH, Akimova T, Liu Y, Wang L, Hancock WW. Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. Curr Opin Immunol 2011; 23:670-8; PMID:21798734; http://dx.doi.org/10.1016/j.coi.2011.07.002
49. Markus HS, Mäkeläa KM, Bevan S, Raitoharju E, Oksala N, Bis JC, O’Donnell C, Hainsworth A, Lehtimäki T. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke 2013; 44:1220-5; PMID:23449258; http://dx.doi.org/10.1161/STROKEAHA.111.000217
50. Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M, Jackson CA, Traylor M, Strange A, Su Z, et al.; International Stroke Genetics Consortium (ISGC); Wellcome Trust Case Control Consortium 2 (WTCCC2). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012; 44:328-33; PMID:22306652; http://dx.doi.org/10.1038/ng.1081